OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
June 4, 2026
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
June 4, 2026
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients
May 27, 2026
KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients
Texas Public Radio: A therapy that could revolutionize cancer treatment is getting a clinical trial in San Antonio
April 17, 2026
Texas Public Radio: A therapy that could revolutionize cancer treatment is getting a clinical trial in San Antonio
Texas Public Radio: TPR News Now: Wednesday, December 10, 2025
December 12, 2025
Texas Public Radio: TPR News Now: Wednesday, December 10, 2025
UT Health San Antonio awarded $3 million CPRIT grant to bolster cancer research and prevention efforts in South Texas
December 12, 2025
UT Health San Antonio received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on Nov. 19 by the Cancer Prevention Research Institute of Texas (CPRIT).
